Tag | Interval | Occurency | Average % | Max % |
---|---|---|---|---|
autoimmunity | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
cancer | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
fibrosis | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
hepatitis | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
hiv | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
metabolic | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
neurological | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
parkinson | 1y | 1 | 1.84848674728993 | 1.84848674728993 |
parkinson | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
autoimmunity | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
hiv | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
cancer | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
neurological | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
fibrosis | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
metabolic | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
hepatitis | 3d | 1 | 0.538133234366313 | 0.538133234366313 |
Sector | Interval | Occurency | Average % | Max % |
---|---|---|---|---|
Health Technology | 1y | 8 | 1.84848674728993 | 1.84848674728993 |
Health Technology | 3d | 8 | 0.538133234366313 | 0.538133234366313 |
Industry | Interval | Occurency | Average % | Max % |
---|---|---|---|---|
Pharmaceuticals: Major | 1y | 8 | 1.84848674728993 | 1.84848674728993 |
Pharmaceuticals: Major | 3d | 8 | 0.538133234366313 | 0.538133234366313 |